{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:49:58Z","timestamp":1793249398481,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Muscle wasting is common in chronic kidney disease (CKD), contributing to impaired function and poor health outcomes. Exercise is recommended, but the molecular responses of skeletal muscle to different exercise modalities remain unclear. This study examined anabolic, catabolic, and myogenic responses to aerobic exercise (AE) versus combined exercise (CE; aerobic plus resistance) in CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Muscle biopsies were collected from participants in a 12-week randomized controlled trial (the ExTra CKD trial) at baseline, 24\u2009hours after initial exercise bout (untrained), and 24\u2009hours after the final session (trained). Western blotting and RT-qPCR assessed markers of protein synthesis, degradation, and regeneration. Complementary in vitro experiments used mechanically stretched primary skeletal muscle cells from CKD patients and healthy controls to investigate the temporal dynamics of anabolic signalling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AE did not alter Akt phosphorylation at any time point (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). In contrast, CE showed no acute effect before training (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05) but significantly increased Akt phosphorylation after training (+118% vs baseline,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02), indicating partial restoration of anabolic signalling. CE also attenuated the acute increase in the 14-kDa actin fragment observed in the untrained state (+253%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04), and increased expression of myogenic marker MyoD following training (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01), whereas AE effects were minimal (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). In vitro mechanical stretch induced marked increases in Akt (CKD: +5651%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012; healthy control: +3437%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028) and p70S6K phosphorylation immediately post-stretch (CKD: +1076%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014; healthy control: +712%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.038). No significant differences in the temporal signalling response were observed between CKD and healthy control cells (P-Akt:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.84; P-P70S6K:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.052).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CE, but not AE alone, elicits beneficial anabolic and myogenic adaptations in skeletal in CKD. Combining in vivo and in vitro approaches offers deeper mechanistic insight into exercise-induced molecular adaptations and highlights the importance of including resistance training to overcome anabolic resistance in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study includes analysis of tissue samples from two clinical trials both registered with the ISRCTN- ExTRa CKD: ISRCTN (no. 36489137, registered 21\/04\/2014) and Explore CKD: ISRCTN (No. 18221837, registered 10\/02\/2016).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-04891-4","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:16:14Z","timestamp":1773371774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anabolic and catabolic responses to different modes of exercise in patients with chronic kidney disease"],"prefix":"10.1186","volume":"27","author":[{"given":"Douglas W.","family":"Gould","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Eastley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert U.","family":"Ashford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Denniff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Graham-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o L.","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Philp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"4891_CR1","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of chronic kidney disease, 1990-2017. A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333.","DOI":"10.1016\/S0140-6736(19)32977-0"},{"issue":"3","key":"4891_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MNH.0000000000000318","volume":"26","author":"RN Moorthi","year":"2017","unstructured":"Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2017;26(3):219\u201328.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10","key":"4891_CR3","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/ndt\/gfv133","volume":"30","author":"RA Pereira","year":"2015","unstructured":"Pereira RA, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transpl. 2015;30(10):1718\u201325.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"4891_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/ndt\/gfz235","volume":"36","author":"TJ Wilkinson","year":"2021","unstructured":"Wilkinson TJ, et al. Prevalence and correlates of physical activity across kidney disease stages: an observational multicentre study. Nephrol Dial Transpl. 2021;36(4):641\u201349.","journal-title":"Nephrol Dial Transpl"},{"key":"4891_CR5","doi-asserted-by":"crossref","unstructured":"Schmid D, Ricci C, Leitzmann MF. Associations of objectively assessed physical activity and sedentary time with all-cause mortality in US adults: the NHANES study. PLoS One. 2015;10(3):e0119591.","DOI":"10.1371\/journal.pone.0119591"},{"issue":"1","key":"4891_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12882-021-02618-1","volume":"23","author":"LA Baker","year":"2022","unstructured":"Baker LA, et al. Clinical practice guideline exercise and lifestyle in chronic kidney disease. BMC Nephrol. 2022;23(1):75.","journal-title":"BMC Nephrol"},{"issue":"5","key":"4891_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1053\/j.jrn.2025.03.009","volume":"35","author":"H Hu","year":"2025","unstructured":"Hu H, et al. Availability of exercise program, perceived exercise benefits and barriers, and exercise habits in maintenance hemodialysis patients: a multicenter cross-sectional study. J Ren Nutr. 2025;35(5):568\u201377.","journal-title":"J Ren Nutr"},{"issue":"1","key":"4891_CR8","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1096\/fj.201901936RR","volume":"34","author":"EL Watson","year":"2020","unstructured":"Watson EL, et al. Reductions in skeletal muscle mitochondrial mass are not restored following exercise training in patients with chronic kidney disease. Faseb J. 2020;34(1):1755\u201367.","journal-title":"Faseb J"},{"issue":"5","key":"4891_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/ndt\/gfab333","volume":"37","author":"EL Watson","year":"2022","unstructured":"Watson EL, et al. Inflammation and physical dysfunction: responses to moderate intensity exercise in chronic kidney disease. Nephrol Dial Transpl. 2022;37(5):860\u201368.","journal-title":"Nephrol Dial Transpl"},{"key":"4891_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3389\/fphys.2017.00541","volume":"8","author":"EL Watson","year":"2017","unstructured":"Watson EL, et al. The effect of resistance exercise on inflammatory and myogenic markers in patients with chronic kidney disease. Front Physiol. 2017;8:541.","journal-title":"Front Physiol"},{"issue":"10","key":"4891_CR11","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.biocel.2013.06.027","volume":"45","author":"XH Wang","year":"2013","unstructured":"Wang XH, Mitch WE. Muscle wasting from kidney failure-a model for catabolic conditions. Int J Biochem Cell Biol. 2013;45(10):2230\u201338.","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"4891_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ki.2009.260","volume":"76","author":"XH Wang","year":"2009","unstructured":"Wang XH, et al. Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function. Kidney Int. 2009;76(7):751\u201359.","journal-title":"Kidney Int"},{"key":"4891_CR13","doi-asserted-by":"crossref","first-page":"329606","DOI":"10.1155\/2013\/329606","volume":"2013","author":"JL Bailey","year":"2013","unstructured":"Bailey JL. Insulin resistance and muscle metabolism in chronic kidney disease. ISRN Endocrinol. 2013;2013:329606.","journal-title":"ISRN Endocrinol"},{"key":"4891_CR14","doi-asserted-by":"crossref","unstructured":"Watson EL, et al. Twelve-week combined resistance and aerobic training confers greater benefits than aerobic training alone in nondialysis CKD. Am J Physiol Renal Physiol. 2018;314(6):F1188\u2013f1196.","DOI":"10.1152\/ajprenal.00012.2018"},{"key":"4891_CR15","doi-asserted-by":"crossref","unstructured":"Baker LA, et al. Establishment and characterisation of primary skeletal muscle cell cultures from patients with advanced chronic kidney disease. bioRxiv. 2020;2020.11.16.384263.","DOI":"10.1101\/2020.11.16.384263"},{"issue":"11","key":"4891_CR16","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1681\/ASN.2006020131","volume":"17","author":"BT Workeneh","year":"2006","unstructured":"Workeneh BT, et al. Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J Am Soc Nephrol. 2006;17(11):3233\u201339.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4891_CR17","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.2337\/db05-1419","volume":"55","author":"A Deshmukh","year":"2006","unstructured":"Deshmukh A, et al. Exercise-induced phosphorylation of the novel Akt substrates AS160 and filamin a in human skeletal muscle. Diabetes. 2006;55(6):1776\u201382.","journal-title":"Diabetes"},{"issue":"2","key":"4891_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2004.05.020","volume":"319","author":"K Sakamoto","year":"2004","unstructured":"Sakamoto K, et al. Exercise regulates Akt and glycogen synthase kinase-3 activities in human skeletal muscle. Biochem Biophys Res Commun. 2004;319(2):419\u201325.","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"4891_CR19","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1111\/febs.12253","volume":"280","author":"S Schiaffino","year":"2013","unstructured":"Schiaffino S, et al. Mechanisms regulating skeletal muscle growth and atrophy. Febs J. 2013;280(17):4294\u2013314.","journal-title":"Febs J"},{"key":"4891_CR20","doi-asserted-by":"crossref","unstructured":"Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1. Am J Physiol Endocrinol Metab. 2014;307(6):E469\u201384.","DOI":"10.1152\/ajpendo.00204.2014"},{"issue":"3","key":"4891_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","volume":"2","author":"Y Elkina","year":"2011","unstructured":"Elkina Y, et al. The role of myostatin in muscle wasting: an overview. J Cachexia Sarcopenia Muscle. 2011;2(3):143\u201351.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"4891_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/ckj\/sfy052","volume":"11","author":"TF O\u2019Sullivan","year":"2018","unstructured":"O\u2019Sullivan TF, Smith AC, Watson EL. Satellite cell function, intramuscular inflammation and exercise in chronic kidney disease. Clin Kidney J. 2018;11(6):810\u201321.","journal-title":"Clin Kidney J"},{"issue":"6","key":"4891_CR23","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.kint.2021.02.027","volume":"99","author":"MPM Graham-Brown","year":"2021","unstructured":"Graham-Brown MPM, et al. A randomized controlled trial to investigate the effects of intra-dialytic cycling on left ventricular mass. Kidney Int. 2021;99(6):1478\u201386.","journal-title":"Kidney Int"},{"issue":"2","key":"4891_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1053\/j.ajkd.2014.10.019","volume":"66","author":"EL Watson","year":"2015","unstructured":"Watson EL, et al. Progressive resistance exercise training in CKD: a feasibility study. Am J Kidney Dis. 2015;66(2):249\u201357.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4891_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1053\/j.ajkd.2014.07.015","volume":"65","author":"SA Greenwood","year":"2015","unstructured":"Greenwood SA, et al. Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial. Am J Kidney Dis. 2015;65(3):425\u201334.","journal-title":"Am J Kidney Dis"},{"key":"4891_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1743-7075-8-68","volume":"8","author":"L Breen","year":"2011","unstructured":"Breen L, Phillips SM. Skeletal muscle protein metabolism in the elderly: interventions to counteract the \u2018anabolic resistance\u2019 of ageing. Nutr Metab (Lond). 2011;8:68.","journal-title":"Nutr Metab (Lond)"},{"key":"4891_CR27","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3389\/fphys.2015.00283","volume":"6","author":"T Snijders","year":"2015","unstructured":"Snijders T, et al. Satellite cells in human skeletal muscle plasticity. Front. Physiol. 2015;6:2015.","journal-title":"Front. Physiol"},{"key":"4891_CR28","doi-asserted-by":"crossref","unstructured":"Coffey VG, et al. Effect of consecutive repeated sprint and resistance exercise bouts on acute adaptive responses in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2009;297(5):R1441\u201351.","DOI":"10.1152\/ajpregu.00351.2009"},{"issue":"4","key":"4891_CR29","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1152\/japplphysiol.91221.2008","volume":"106","author":"VG Coffey","year":"2009","unstructured":"Coffey VG, et al. Consecutive bouts of diverse contractile activity alter acute responses in human skeletal muscle. J Appl Physiol (1985). 2009;106(4):1187\u201397.","journal-title":"J Appl Physiol (1985)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04891-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04891-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04891-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:53:37Z","timestamp":1781639617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04891-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4891"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04891-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8374768\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the ExTra CKD study: Recruitment occurred between 16\n                      th\n                      December 2013 and 30\n                      th\n                      April 2016, with all interventions completed by October 2016. Ethical approval was obtained from the UK National Research Ethics Committee (Ref: 13\/EM\/0344), and the trial was registered with the ISRCTN (no. 36489137). The study was conducted in accordance with the Declaration of Helsinki, and all participants provided written informed consent. For the Explore CKD study: The study received ethical approval from the UK National Research Ethics Committee (Ref: 15\/EM\/0467) and registered with ISRCTN (No. 18221837). All procedures conformed to the Declaration of Helsinki, and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors confirm there are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}